Remove 2019 Remove Data Remove Epilepsy Remove Safety
article thumbnail

FDA Stresses CBD Safety Concerns in 15 Warning Letters and Revised Consumer Update

The Blunt Truth

In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly. The FDA also highlighted the issue it has proclaimed since May 2019, when the CBD Policy Working Group held a public hearing–“many unanswered questions and data gaps about CBD toxicity” remain.

Safety 68
article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tyson and Holyfield Announce Edibles, Texas’ Medical Cannabis Gains, and Big Hemp Study

Veriheal

According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.

Edibles 97
article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59
article thumbnail

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. In 2021, CBD sales in the natural channel totaled $38,931,696, a 24% decline.

CBD 144
article thumbnail

CBD for Pets Yes the Data says it works !

Cannabis Info

CBD for Pets Yes the Data says it works ! Lets review some data. Since then, numerous studies have provided lots of clinical data that CBD can help manage a wide variety of tremors, spasms, and tics. Several months ago, there was a thunder and lightning storm and my dog, Jing, went under the bed for safety as fast as she could….She

Pets 45